These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A Randomized Controlled Trial Comparing the Success of Mineral Trioxide Aggregate and Ferric Sulfate as Pulpotomy Medicaments for Primary Molars. Cordell S; Kratunova E; Marion I; Alrayyes S; Alapati SB J Dent Child (Chic); 2021 May; 88(2):120-128. PubMed ID: 34321144 [No Abstract] [Full Text] [Related]
4. Efficacy of orthoMTA, retroMTA and ferric sulphate as pulpotomy agents in primary molars: a randomized clinical trial. Yilmaz S; Keles S Eur Oral Res; 2023 Sep; 57(3):144-150. PubMed ID: 37929220 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Clinical and Radiological Outcomes of Pulpotomized Primary Molars Treated with Three Different Materials: Mineral Trioxide Aggregate, Biodentine, and Pulpotec. An In-vivo Study. Mythraiye R; Rao VV; Minor Babu MS; Satyam M; R P; Paravada C Cureus; 2019 Jun; 11(6):e4803. PubMed ID: 31404393 [TBL] [Abstract][Full Text] [Related]
6. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial. Cuadros-Fernández C; Lorente Rodríguez AI; Sáez-Martínez S; García-Binimelis J; About I; Mercadé M Clin Oral Investig; 2016 Sep; 20(7):1639-45. PubMed ID: 26578117 [TBL] [Abstract][Full Text] [Related]
7. Comparative Evaluation of the Treatment Outcomes of Pulpotomy in Primary Molars Using Mineral Trioxide Aggregate and 3Mixtatin: A Randomized Clinical Trial. Mushtaq A; Nangia T; Goswami M Int J Clin Pediatr Dent; 2023; 16(6):810-815. PubMed ID: 38344366 [TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth. Srinivasan D; Jayanthi M Indian J Dent Res; 2011; 22(3):385-90. PubMed ID: 22048576 [TBL] [Abstract][Full Text] [Related]
10. MTA and ferric sulfate in pulpotomy outcomes of primary molars: a systematic review and meta-analysis. Asgary S; Shirvani A; Fazlyab M J Clin Pediatr Dent; 2014; 39(1):1-8. PubMed ID: 25631717 [TBL] [Abstract][Full Text] [Related]
11. Effect of mineral trioxide aggregate and formocresol pulpotomy on vital primary teeth: a clinical and radiographic study. Olatosi OO; Sote EO; Orenuga OO Niger J Clin Pract; 2015; 18(2):292-6. PubMed ID: 25666010 [TBL] [Abstract][Full Text] [Related]
12. Effects of mineral trioxide aggregate and formocresol on vital pulp after pulpotomy of primary molars: An in vivo study. Godhi B; Sood PB; Sharma A Contemp Clin Dent; 2011 Oct; 2(4):296-301. PubMed ID: 22346156 [TBL] [Abstract][Full Text] [Related]
13. Treatment Outcomes of Pulpotomy with Propolis in Comparison with MTA in Human Primary Molars: A 24-month Follow-up Randomized Controlled Trial. RojaRamya KS; Chandrasekhar R; Uloopi KS; Vinay C Int J Clin Pediatr Dent; 2022; 15(Suppl 1):S3-S7. PubMed ID: 35645503 [TBL] [Abstract][Full Text] [Related]
14. Success rate of three capping materials used in pulpotomy of primary molars: A randomized clinical trial. Abd Al Gawad RY; Hanafy RMH Saudi Dent J; 2021 Nov; 33(7):560-567. PubMed ID: 34803301 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of formocresol, calcium hydroxide, ferric sulfate, and MTA primary molar pulpotomies. Yildiz E; Tosun G Eur J Dent; 2014 Apr; 8(2):234-240. PubMed ID: 24966776 [TBL] [Abstract][Full Text] [Related]
17. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars. Noorollahian H Br Dent J; 2008 Jun; 204(11):E20. PubMed ID: 18425074 [TBL] [Abstract][Full Text] [Related]